Digal, Metchelyn C.
HRN: 27-11-77 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2025
CEFUROXIME 750MG (VIAL)
07/01/2025
07/08/2025
IV
750mg
Q8h
Basal Cell Carcinoma, Nasal
Checking Initial Appropriateness